Cognition Therapeutics’ dementia drug showed up to a 129% slowing of cognitive decline in mild Alzheimer’s disease patients ...

Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the ...

Higher brain copper levels are linked to slower cognitive decline and lower Alzheimer’s pathology, shows a 20-year study.

BBM tests with ≥90% sensitivity and ≥75% specificity can be used as a triaging test, in which a negative result rules out ...

Adopting intensive lifestyle changes can slow or stop progression of early-stage Alzheimer’s disease, according to a new study.

The disease has been diagnosed in more than 100 former NFL players and arisen as an existential threat to the United States’ ...

A new drug cleared 91% of brain amyloid plaques in 7 months, showing faster results than current Alzheimer's treatments and advancing to Phase III trials in 2025.

Experts don't back specific tests, but provide guidelines on how doctors in specialty care settings can use them to diagnose ...